Patents by Inventor Julia Reid

Julia Reid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER BIOMARKERS
    Publication number: 20170247768
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: May 5, 2017
    Publication date: August 31, 2017
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • GENE SIGNATURES FOR CANCER PROGNOSIS
    Publication number: 20170152571
    Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.
    Type: Application
    Filed: November 11, 2016
    Publication date: June 1, 2017
    Inventors: Steven Stone, Alexander Gutin, Julia Reid
  • GENE SIGNATURES FOR CANCER DIAGNOSIS AND PROGNOSIS
    Publication number: 20170096712
    Abstract: Biomarkers and methods using the biomarkers for molecular detection and classification of disease and, particularly, molecular markers for cancer diagnosis and prognosis and methods of use thereof are provided.
    Type: Application
    Filed: August 15, 2016
    Publication date: April 6, 2017
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • Gene signatures for cancer diagnosis and prognosis
    Patent number: 9605319
    Abstract: Biomarkers and methods using the biomarkers for molecular detection and classification of disease and, particularly, molecular markers for cancer diagnosis and prognosis and methods of use thereof are provided.
    Type: Grant
    Filed: August 30, 2011
    Date of Patent: March 28, 2017
    Assignee: Myriad Genetics, Inc.
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • GENE SIGNATURES FOR RENAL CANCER PROGNOSIS
    Publication number: 20160281177
    Abstract: Biomarkers and methods using the biomarkers for prognosis of renal cancer in a patient are provided.
    Type: Application
    Filed: June 2, 2016
    Publication date: September 29, 2016
    Inventors: Steven Stone, Julia Reid, Eric J. Askeland, James A. Brown
  • GENE SIGNATURES FOR CANCER PROGNOSIS
    Publication number: 20150247208
    Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.
    Type: Application
    Filed: May 15, 2015
    Publication date: September 3, 2015
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • CANCER BIOMARKERS
    Publication number: 20150232947
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: February 26, 2015
    Publication date: August 20, 2015
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • GENE SIGNATURES FOR LUNG CANCER PROGNOSIS AND THERAPY SELECTION
    Publication number: 20140315935
    Abstract: The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof.
    Type: Application
    Filed: February 21, 2014
    Publication date: October 23, 2014
    Inventors: Susanne Wagner, Steven Stone, Alexander Gutin, Julia Reid
  • HYPOXIA-RELATED GENE SIGNATURES FOR CANCER CLASSIFICATION
    Publication number: 20140212415
    Abstract: Biomarkers, particularly hypoxia-related genes, and methods using the biomarkers for molecular classification of disease are provided.
    Type: Application
    Filed: February 4, 2014
    Publication date: July 31, 2014
    Inventors: Alexander Gutin, Srikanth Jammulapati, Susanne Wagner, Julia Reid, Darl Flake
  • GENE SIGNATURES FOR LUNG CANCER PROGNOSIS AND THERAPY SELECTION
    Publication number: 20140170242
    Abstract: The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof.
    Type: Application
    Filed: February 19, 2014
    Publication date: June 19, 2014
    Inventors: Susanne Wagner, Steven Stone, Alexander Gutin, Julia Reid
  • GENE SIGNATURES FOR CANCER DIAGNOSIS AND PROGNOSIS
    Publication number: 20130302242
    Abstract: Biomarkers and methods using the biomarkers for molecular detection and classification of disease and, particularly, molecular markers for cancer diagnosis and prognosis and methods of use thereof are provided.
    Type: Application
    Filed: August 30, 2011
    Publication date: November 14, 2013
    Applicant: MYRIAD GENETICS, INC.
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • GENE SIGNATURES FOR CANCER PROGNOSIS
    Publication number: 20120053253
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: July 7, 2011
    Publication date: March 1, 2012
    Applicant: Myriad Genetics, Incorporated
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • CANCER BIOMARKERS
    Publication number: 20120041274
    Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
    Type: Application
    Filed: July 7, 2011
    Publication date: February 16, 2012
    Applicant: Myriad Genetics, Incorporated
    Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
  • Gene variants and use thereof
    Publication number: 20070082347
    Abstract: Variants in TLK1, WARS2, ARTS2, MSR, AKAP9, DNAJD1, GOLPH4, RABEP1, TAP2, NARG2, DDX58, CD39, FKBP1a, SRI, XRRA1, IRF5 and AMFR genes are disclosed which are useful as biomarkers for predicting the TLK1, WARS2, ARTS2, MSR, AKAP9, DNAJD1, GOLPH4, RABEP1, TAP2, NARG2, DDX58, CD39, FKBP1a, SRI, XRRA1, IRF5 or AMFR gene expression level and the biological functions associated thereof.
    Type: Application
    Filed: June 8, 2006
    Publication date: April 12, 2007
    Applicant: Myriad Genetics, Incorporated
    Inventors: Jerry Lanchbury, Alexander Gutin, Andrey Zharkikh, Julia Reid, Kirsten Timms, Susanne Wagner, Ann-Marie Woodland
  • Drug response marker in beta-1 adrenergic receptor gene
    Patent number: 7195873
    Abstract: Methods of using a genetic polymorphic variation in the human beta-1 adrenergic receptor gene as a drug response marker are presented. Determining the presence or absence of the A145G genetic variation in the human beta-1 adrenergic receptor gene is useful in predicting an individual's relative response to different antihypertensive drugs; optimizing antihypertensive treatment for an individual; selecting candidate human subjects for participation in clinical trials involving antihypertensive drugs; and, predicting the relative responses among a plurality of individuals to an antihypertensive drug.
    Type: Grant
    Filed: December 27, 2002
    Date of Patent: March 27, 2007
    Assignee: Myriad Genetics, Inc.
    Inventors: Fabiana Filigheddu, Julia Reid, Susanne Wagner
  • Drug response marker in beta-1 adrenergic receptor gene
    Publication number: 20030143608
    Abstract: Methods of using a genetic polymorphic variation in the human beta-1 adrenergic receptor gene as a drug response marker are presented. Determining the presence or absence of the A145G genetic variation in the human beta-1 adrenergic receptor gene is useful in predicting an individual's relative response to different antihypertensive drugs; optimizing antihypertensive treatment for an individual; selecting candidate human subjects for participation in clinical trials involving antihypertensive drugs; and, predicting the relative responses among a plurality of individuals to an antihypertensive drug.
    Type: Application
    Filed: December 27, 2002
    Publication date: July 31, 2003
    Applicant: Myriad Genetics, Incorporated
    Inventors: Fabiana Filigheddu, Julia Reid, Susanne Wagner